Transendothelial migration of lymphocytes from HIV-1-infected donors: a mechanism for extravascular dissemination of HIV-1.
To identify factors that cause HIV-1 to establish perivascular foci of infected cells, we studied the transendothelial migration of blood mononuclear leukocytes (MNL) from 76 HIV+ patients and 41 controls. The fraction of patients' lymphocytes that migrated across endothelial cell monolayers in vitro was significantly increased (p < or = 0.03) compared with that of control donors. Migration of patients' CD4+ T cells was particularly enhanced, whereas the migration of monocytes did not differ between patients and controls. Lymphocyte migration correlated with expression of CD11a/CD18 and CD49d/CD29 and with the quantity of TNF-alpha produced as MNLs migrated through the endothelium. Measurement of HIV-1 proviral DNA copies in the patients' MNLs (n = 26) suggested that in half the cases virus-infected cells accumulated preferentially amidst the migratory leukocytes. We observed the same behavior with normal donor MNLs infected, in vitro, with each of 4 strains of HIV-1. The number of HIV-1 proviral DNA copies per million MNLs was 40 to 178 times higher in the migratory population than in the original population added to the endothelium. To test whether only certain strains of HIV-1 stimulate transendothelial migration of infected cells, we used single strand conformation polymorphism analysis to identify quasispecies of HIV-1 in the MNLs. If all strains of HIV-1 were equal in their ability to stimulate transendothelial migration, we expected to find no differences in the quasispecies present in the original and migratory cell populations. In fact the quasispecies differed in 14 of 19 paired samples, suggesting that only certain HIV-1 quasispecies promote transendothelial migration of infected cells.
Birdsall
H H
HH
Research Center for AIDS and HIV Infections, the Immunology Research Laboratory at the Veterans Affairs Medical Center, Baylor College of Medicine, Houston, TX 77030, USA. birdsall@bcm.tmc.edu
Trial
J
J
Lin
H J
HJ
Green
D M
DM
Sorrentino
G W
GW
Siwak
E B
EB
de Jong
A L
AL
Rossen
R D
RD
D000163:Acquired Immunodeficiency Syndrome / Q000473:pathology* / Q000821:virology*; D015703:Antigens, CD / Q000032:analysis; D018821:CD18 Antigens / Q000032:analysis; D015496:CD4-Positive T-Lymphocytes / Q000502:physiology; D002465:Cell Movement / Q000502:physiology*; D004730:Endothelium, Vascular / Q000473:pathology*; D015497:HIV-1; D006801:Humans; D039441:Integrin alpha4; D019012:Integrin beta1 / Q000032:analysis; D016169:Lymphocyte Function-Associated Antigen-1 / Q000032:analysis; D008214:Lymphocytes / Q000502:physiology* / Q000821:virology; D009000:Monocytes / Q000502:physiology
D015703:Antigens, CD; D018821:CD18 Antigens; D019012:Integrin beta1; D016169:Lymphocyte Function-Associated Antigen-1; D039441:Integrin alpha4